During the past decade, Magnolia Ob/Gyn Research Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Magnolia Ob/Gyn Research Center" #1 sponsor was "Curatek Pharmaceuticals, LLC" with 1 trials, followed by "Estetra" with 1 trials sponsored, "Inovio Pharmaceuticals" with 1 trials sponsored, "Mereo BioPharma" with 1 trials sponsored and "Millendo Therapeutics US, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magnolia Ob/Gyn Research Center" #1 collaborator was "Covance" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Magnolia Ob/Gyn Research Center" are "Candida Vulvovaginitis" (1 trials), "Cervical Dysplasia" (1 trials), "Cervical High Grade Squamous Intraepithelial Lesion" (1 trials), "HSIL" (1 trials) and "Menopausal Symptoms" (1 trials). Many other conditions were trialed in "Magnolia Ob/Gyn Research Center" in a lesser frequency.

Most popular intervention types in "Magnolia Ob/Gyn Research Center" are "Drug" (5 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BGS649" (1 trials), "Electroporation (EP)" (1 trials), "Estetrol oral tablet" (1 trials) and "Ibrexafungerp" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magnolia Ob/Gyn Research Center" are 7 trials for "Female" genders.

Currently, there are NaN active trials in "Magnolia Ob/Gyn Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Magnolia Ob/Gyn Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Magnolia Ob/Gyn Research Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".